...
首页> 外文期刊>Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy >Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease.
【24h】

Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease.

机译:慢性血液透析患者严重动脉粥样硬化改变的证据:针对没有慢性肾脏疾病的心血管疾病患者的比较尸检研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Atherosclerosis is a major cause of mortality and morbidity among hemodialysis patients, but whether it is more severe in hemodialysis patients than in cardiovascular disease patients without chronic kidney disease is unclear. We examined 46 autopsy patients who had undergone hemodialysis, and age and sex-matched 46 patients with cardiovascular disease and an eGFR of >60 mL/min/1.73 m(2). There was no difference in the prevalence of diabetes or hypertension between the groups. We divided the aorta into four segments: A, ascending artery to arch; B, descending artery to diaphragm; C, suprarenal; and D, infrarenal. We used the classification of the American Heart Association to evaluate atherosclerosis progression. Distribution was scored by the extent to which each segment was damaged: 0, none; 1, less than 1/3; 2, more than 1/3 to less than 2/3; 3, more than 2/3. Histological examination revealed that the progression score (P < 0.05) and distribution score (P<0.005) were more severe in the hemodialysis group, especially in segment A. Regression analysis showed that atherosclerosis of segment A was related to age, gender, dyslipidemia, smoking, hemodialysis therapy, and hemodialysis duration. In hemodialysis patients, atherosclerotic changes in the aorta were more severe than in cardiovascular disease patients with an eGFR of >60 mL/min/1.73 m(2). Aortic atherosclerosis was aggravated by traditional and chronic kidney disease-related risk factors.
机译:动脉粥样硬化是血液透析患者死亡率和发病率的主要原因,但是尚不清楚血液透析患者是否比没有慢性肾脏疾病的心血管疾病患者更为严重。我们检查了46例接受血液透析的尸检患者,以及年龄和性别相匹配的46例心血管疾病患者,其eGFR大于60 mL / min / 1.73 m(2)。两组之间的糖尿病或高血压患病率无差异。我们将主动脉分为四个部分:A,升主动脉至弓; B,降动脉至横diaphragm膜; C,肾上; D,肾下。我们使用美国心脏协会的分类来评估动脉粥样硬化的进展。通过每个分段损坏的程度对分布进行评分:0,无; 1,小于1/3; 2,大于1/3至小于2/3; 3,大于2/3。组织学检查显示,血液透析组的进展评分(P <0.05)和分布评分(P <0.005)更为严重,尤其是在A段。回归分析显示,A段的动脉粥样硬化与年龄,性别,血脂异常,吸烟,血液透析疗法和血液透析持续时间。在血液透析患者中​​,主动脉粥样硬化的变化比eGFR> 60 mL / min / 1.73 m(2)的心血管疾病患者更为严重。传统的和慢性的肾脏疾病相关的危险因素加剧了主动脉粥样硬化。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号